NTRA
NASDAQ · Biotechnology
Natera Inc
$194.24
-25.58 (-11.64%)
Performance
1D
—
1W
—
1M
—
3M
-8.23%
6M
-7.28%
1Y
+23.49%
YTD
-15.12%
Open$210.00
Previous Close$219.82
Day High$217.65
Day Low$192.52
52W High$256.36
52W Low$131.81
Volume—
Avg Volume1.47M
Market Cap27.65B
P/E Ratio—
EPS$-1.53
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$229.31
Below
SMA 200
$186.42
Above
RSI (14)
38.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-26.4% upside
Current
$194.24
$194.24
Target
$142.91
$142.91
$88.14
$142.91 avg
$188.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.40B | 1.70B | 5.13B |
| Net Income | -216,691,231 | -138,176,355 | 875.75M |
| Profit Margin | -9.0% | -8.6% | 17.1% |
| EBITDA | -320,831,115 | -215,948,391 | 1.33B |
| Free Cash Flow | — | — | 778.23M |
| Rev Growth | +41.1% | +41.1% | +14.5% |
| Debt/Equity | 0.05 | 0.05 | 1.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |